Hassan Joanne, Wangai Laura, Borus Peter, Khayeka-Wandabwa Christopher, Karani Lucy Wanja, Kithinji Mercy, Kiptoo Michael
Institute of Tropical Medicine and Infectious Diseases (ITROMID), Jomo Kenyatta University of Agriculture and Technology (JKUAT), Juja, Kenya.
Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
BMC Res Notes. 2017 Nov 3;10(1):555. doi: 10.1186/s13104-017-2843-y.
Poliomyelitis is an acute viral infection caused by poliovirus and transmitted via the fecal-oral route. The causative agent is one of the three serotypes of poliovirus (serotypes 1, 2, 3) that differ slightly in capsid protein. Prolonged vaccine-related poliovirus shedding in human immunodeficiency virus (HIV) positive individuals has been linked to possible reservoir for reintroduction of polioviruses after eradication. The study therefore aimed at estimating the duration for vaccine-related poliovirus shedding among potentially and HIV-infected persons.
Poliovirus excretion was studied following vaccination of children aged ≤ 59 month per human immunodeficiency virus status after national immunization days. Their medical records were reviewed to identify the child's HIV status, demographic and immunization data. Sequential stool samples were collected at site 2nd, 4th and 8th week after trivalent oral poliovirus vaccine (tOPV) was administered. To isolate suspected polioviruses and non-polio enteroviruses, characterize poliovirus subtypes by intratypic differentiation and Sabin vaccine derived poliovirus, real time polymerase chain reaction was applied. Shedding for ≥ 24 weeks was defined as long-term persistence.
The mean age of the study population was 28.6 months, while the median age was 24 months. Of the children recruited, majority were in the 25-48 months (n = 12; 46.2%) age category. All the HIV-positive children (n = 10) had mild symptomatic HIV status and did shed vaccine-related polioviruses between weeks 2 and 4 respectively. No participant shed polioviruses for ≥ 6 weeks.
It was evident mildly symptomatic HIV+ children sustain the capacity to clear vaccine-related poliovirus. The oral poliovirus vaccine-2 (Sabin like) that was detected in one HIV-infected child's stool 6 weeks after the national immunization days was predominantly non revertant. There was no evident prolonged poliovirus shedding among the participants enlisted in the present study. High powered studies are desired to further corroborate these findings.
脊髓灰质炎是由脊髓灰质炎病毒引起的急性病毒感染,通过粪-口途径传播。病原体是脊髓灰质炎病毒三种血清型(血清型1、2、3)之一,其衣壳蛋白略有不同。人类免疫缺陷病毒(HIV)阳性个体中与疫苗相关的脊髓灰质炎病毒长期排毒与根除后脊髓灰质炎病毒重新引入的可能储存库有关。因此,该研究旨在估计潜在感染和HIV感染人群中与疫苗相关的脊髓灰质炎病毒排毒持续时间。
在全国免疫日之后,根据儿童的HIV感染状况,对年龄≤59个月的儿童进行疫苗接种后研究脊髓灰质炎病毒排泄情况。查阅他们的病历以确定儿童的HIV感染状况、人口统计学和免疫数据。在口服三价脊髓灰质炎病毒疫苗(tOPV)后的第2、4和8周在现场采集连续的粪便样本。为了分离疑似脊髓灰质炎病毒和非脊髓灰质炎肠道病毒,通过型内鉴别和萨宾疫苗衍生的脊髓灰质炎病毒来鉴定脊髓灰质炎病毒亚型,应用实时聚合酶链反应。持续≥24周的排毒被定义为长期持续排毒。
研究人群的平均年龄为28.6个月,中位年龄为24个月。在招募的儿童中,大多数处于25-48个月龄组(n = 12;46.2%)。所有HIV阳性儿童(n = 10)的HIV症状均较轻,分别在第2周和第4周排出了与疫苗相关的脊髓灰质炎病毒。没有参与者排出脊髓灰质炎病毒≥6周。
显然,症状较轻的HIV+儿童有清除与疫苗相关的脊髓灰质炎病毒的能力。在全国免疫日6周后,在一名HIV感染儿童的粪便中检测到的口服脊髓灰质炎病毒疫苗-2(类萨宾株)主要是非回复株。在本研究纳入的参与者中没有明显的脊髓灰质炎病毒长期排毒情况。需要开展大规模研究以进一步证实这些发现。